BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 366692)

  • 21. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
    Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
    Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathologicoanatomical characteristics of the most important forms of non-Hodgkin malignant lymphomas (based on the Kiel classification)].
    Shtern RD
    Arkh Patol; 1980; 42(11):71-80. PubMed ID: 7004413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
    Płuzańska A; Polkowska-Kulesza E; Robak T; Kuźmicka J; Mazurowa A; Szadowska A; Woźniak L
    Acta Haematol Pol; 1980; 11(1):31-9. PubMed ID: 6966115
    [No Abstract]   [Full Text] [Related]  

  • 24. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
    Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
    J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
    [No Abstract]   [Full Text] [Related]  

  • 26. Preliminary observations on immunologic phenotypes of non-Hodgkin's lymphoma in Indian subjects.
    Bhargava M; Tickoo SK; Kumar R; Kochupillai V
    Indian J Med Res; 1987 Mar; 85():289-91. PubMed ID: 3111998
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and prognostic significance of the T-B immunological classification of non-Hodgkin's lymphomas.
    Ogasawara H; Fujitani T; Mizojiri G; Hattori H
    Laryngoscope; 1981 Jan; 91(1):125-32. PubMed ID: 7005580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant lymphomas of B-cell type.
    Stein H; Lennert K; Parwaresch MR
    Lancet; 1972 Oct; 2(7782):855-7. PubMed ID: 4116558
    [No Abstract]   [Full Text] [Related]  

  • 31. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
    Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
    Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
    Borowitz MJ; Croker BP; Metzgar RS
    Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiinstitution study of non-Hodgkin's lymphomas using frozen section immunoperoxidase: the Southeastern Cancer Study Group experience.
    Borowitz MJ; Newby S; Brynes RK; Cousar JB; Whitcomb CC; Crissman JD; Byrne GE; Collins RD
    Blood; 1984 May; 63(5):1147-52. PubMed ID: 6370333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Categorization of non-Hodgkin's hematosarcomas (lymphomas) according to T- and B-cell markers: its value for diagnosis and prognosis.
    Belpomme D; Caillou B; Lelarge N; Botto I; Pujade Lauraine E; Denaro L; Gerard-Marchant R; Davies AJ; Mathé G
    Recent Results Cancer Res; 1978; 64():146-57. PubMed ID: 366693
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
    Weiss LM; Yousem SA; Warnke RA
    Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.
    Stein H; Lennert K; Feller AC; Mason DY
    Adv Cancer Res; 1984; 42():67-147. PubMed ID: 6395656
    [No Abstract]   [Full Text] [Related]  

  • 38. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.
    Nanba K; Jaffe ES; Braylan RC; Soban EJ; Berard CW
    Am J Clin Pathol; 1977 Nov; 68(5):535-42. PubMed ID: 335871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Hodgkin's lymphomas: introduction.
    Moreno-Nogueira JA; Casas A; Iglesias Perez L; Andrev-Kern F
    Cancer Clin Trials; 1979; 2(1):63-9. PubMed ID: 391432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.